Pensions & Investments Logo
ETF Exchange > XBI ETF

XBI - ETF Fact Sheet

State Street SPDR S&P Biotech ETF - USD

Fund Identification

Ticker

XBI

ISIN

US78464A8707

Main Metrics

Price

$154.38

Expense Ratio

0.35%

AuM

$10,528.64M

Tracking Difference

-0.28%

Ratings

Trackinsight rating

Official Investment Strategy

The SPDR® S&P® Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P® Biotechnology Select IndustryTM Index. The S&P Biotechnology Select IndustryTM Index represents the biotechnology sub-industry portion of the S&P Total Markets IndexTM. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ® National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

XBI's historical prices, performance, and flows

05101520%
1m returns
14%
1m flows
$897M
* Net total returns
All data as of 17 July 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all XBI data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

XBI's characteristics

Manager statistics

379 funds, $2,253.83Bn in AUM

Benchmark

S&P Biotechnology Select Industry Total Return Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing
XBI's exposure

Countries

USA
95.06%

Sectors

Healthcare
99.64%

Top 5 holdings

Travere Therapeutics, Inc.
1.79%
Revolution Medicines, Inc.
1.78%
Alkermes Plc
1.71%
Twist Bioscience Corp.
1.60%
TG Therapeutics, Inc.
1.52%
Total holdings
143
Total weight of top 5
8.40%
20%